Hereditary acrokeratotic poikiloderma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2907Q82.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hereditary acrokeratotic poikiloderma, also known as Weary-Kindler syndrome or Kindler syndrome (though distinct from the more commonly referenced Kindler syndrome associated with FERMT1 mutations), is a rare inherited skin disorder characterized by the combination of poikiloderma and acrokeratosis. Poikiloderma refers to a pattern of skin changes that includes areas of increased and decreased pigmentation (hyper- and hypopigmentation), skin atrophy (thinning), and telangiectasia (small dilated blood vessels visible on the skin surface). Acrokeratosis refers to thickening of the skin (keratosis) on the extremities, particularly the hands and feet. These skin findings typically develop in early childhood and may progressively worsen over time. The condition primarily affects the integumentary system (skin). Key clinical features include widespread poikilodermatous changes on sun-exposed and non-exposed areas, keratotic (thickened) papules and plaques on the dorsal hands, feet, elbows, and knees, and photosensitivity in some patients. Additional features may include nail dystrophy, mild blistering in infancy, and mucosal involvement. The skin changes can be cosmetically significant and may cause discomfort. There is no specific curative treatment for hereditary acrokeratotic poikiloderma. Management is primarily supportive and symptomatic, including sun protection, emollients, and careful monitoring of skin lesions. Retinoids have been tried in some cases with variable results. Regular dermatologic follow-up is recommended to monitor for any complications.

Also known as:

Clinical phenotype terms— hover any for plain English:

Dystrophic toenailHP:0001810Premature loss of primary teethHP:0006323Dystrophic fingernailsHP:0008391
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hereditary acrokeratotic poikiloderma.

View clinical trials →

No actively recruiting trials found for Hereditary acrokeratotic poikiloderma at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hereditary acrokeratotic poikiloderma community →

No specialists are currently listed for Hereditary acrokeratotic poikiloderma.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hereditary acrokeratotic poikiloderma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hereditary acrokeratotic poikilodermaForum →

No community posts yet. Be the first to share your experience with Hereditary acrokeratotic poikiloderma.

Start the conversation →

Latest news about Hereditary acrokeratotic poikiloderma

No recent news articles for Hereditary acrokeratotic poikiloderma.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hereditary acrokeratotic poikiloderma

What is Hereditary acrokeratotic poikiloderma?

Hereditary acrokeratotic poikiloderma, also known as Weary-Kindler syndrome or Kindler syndrome (though distinct from the more commonly referenced Kindler syndrome associated with FERMT1 mutations), is a rare inherited skin disorder characterized by the combination of poikiloderma and acrokeratosis. Poikiloderma refers to a pattern of skin changes that includes areas of increased and decreased pigmentation (hyper- and hypopigmentation), skin atrophy (thinning), and telangiectasia (small dilated blood vessels visible on the skin surface). Acrokeratosis refers to thickening of the skin (keratosi

How is Hereditary acrokeratotic poikiloderma inherited?

Hereditary acrokeratotic poikiloderma follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hereditary acrokeratotic poikiloderma typically begin?

Typical onset of Hereditary acrokeratotic poikiloderma is childhood. Age of onset can vary across affected individuals.